Amgen Crashes 12% After Obesity Drug Meets Lilly's In A Key Test

Amgen Crashes 12% After Obesity Drug Meets Lilly's In A Key Test

Patients in a study lost 20% of body weight over a year with Amgen's drug, MariTide, given monthly. However, 11% dropped out due to side effects, mainly gastrointestinal. Side effects were mild, transient, and reduced with dose escalation.

Read More

Did you find this insightful?